VERSANT & APTIMA HCV RNA QUALITATIVE ASSAY
FDA premarket approval P020011/S002 · decided 2010-09-17
Approval details
- PMA number
- P020011
- Supplement
- S002
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- VERSANT & APTIMA HCV RNA QUALITATIVE ASSAY
- Generic name
- Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
- Applicant
- Gen-Probe
- Date received
- 2010-02-23
- Decision date
- 2010-09-17
- Days to decision
- 206 days
- Decision code
- APPR
- Product code
- MZP
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- San Diego, CA
- Statement
- APPROVAL FOR A CHANGE IN QUALITY CONTROL SPECIFICATIONS FOR THE HCV CALIBRATORS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.